Combining amoxicillin and relebactam provides a new therapeutic option for Mycobacterium abscessus infection
R. C. Lopeman, J. Harrison, S. E. R. Gibson, D. L. Rathbone, M. Desai, P. A. Lambert, J. A. G. Cox
This paper shows that combining amoxicillin and relebactam synergistically inhibits Mycobacterium abscessus through non-competitive inhibition of its beta-lactamase, offering a new therapeutic option for infections.
bioRxiv · Apr 17, 2019 · PreprintMicrobiology